UBS Lux Equity Fund Biotech USD vs Berkshire Hathaway

UBS Lux Equity Fund Biotech USD vs Berkshire Hathaway

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

2. Berkshire Hathaway

  • Security

    Berkshire Hathaway Inc Class A

  • ISIN

    US0846701086

  • Holdings

    9

Fund Holdings

We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.9) and Moderna (9.21). In comparison with Berkshire Hathaway, we have 16 holdings where Apple is the largest holding (21.1), followed by American Express (14.3) and Coca-Cola (11.2).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Berkshire Hathaway.

UBS Lux Equity Fund Biotech USD Berkshire Hathaway
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Apple Inc
USA
21.1 %
2. Vertex Pharmaceuticals Inc
9.9 %
2. American Express Co
USA
14.3 %
3. Moderna Inc
9.21 %
3. Coca-Cola Company
USA
11.2 %
4. Alnylam Pharmaceuticals Inc
6.54 %
4. Bank of America Corp
USA
9.7 %
5. AbbVie Inc
USA
5.52 %
5. Chevron Corp
USA
6.6 %
6. Gilead Sciences Inc
USA
4.66 %
6. Moody's Corp
USA
4 %
7. Amgen Inc
4.32 %
7. Occidental Petroleum Corp
USA
3.9 %
8. BioNTech SE
4.13 %
8. Kraft Heinz Co
3.7 %
9. Karuna Therapeutics Inc
3.75 %
9. Chubb Ltd
3 %
10. Royalty Pharma Plc
3.28 %
-

The list of fund holdings was last updated on April 17, 2025.